BioCentury
ARTICLE | Clinical News

North American Vaccine regulatory update

February 12, 1996 8:00 AM UTC

NVX's acellular pertussis vaccine received approval in Sweden for all primary and booster doses for infants and children. The vaccine is formulated as a combination DTaP vaccine to prevent diphtheria,...